The International Stem Cell Corporation, a Company Dedicated to Curing Parkinson’s Disease – Huffington Post
Huffington Post |
The International Stem Cell Corporation, a Company Dedicated to Curing Parkinson’s Disease
Huffington Post These scientists created the first non-embryonic human stem cells. This discovery made finding cures for Parkinson’s disease and corneal disease more promising. Currently, some of ISCO’s most promising research is in the field of Parkinson’s disease. |
Huffington Post |
The International Stem Cell Corporation, a Company Dedicated to Curing Parkinson’s Disease
Huffington Post These scientists created the first non-embryonic human stem cells. This discovery made finding cures for Parkinson’s disease and corneal disease more promising. Currently, some of ISCO’s most promising research is in the field of Parkinson’s disease. |
Belfast Telegraph |
Immunotherapy drug nivolumab ruled too costly for head and neck cancer patients
Belfast Telegraph … doctors will not be able to offer this game-changing immunotherapy to patients with advanced head and neck cancer. “Once it has relapsed or spread, the disease is extremely difficult to treat and options, including surgery and radiotherapy, are … Nivolumab not recommend for relapsed or metastatic head-and-neck cancer on the NHSThe Institute of Cancer Research |
Civil Eats |
CRISPR: Is It Possible to Remove Disease From DNA? – WebMD
WebMD A new gene-editing technique called CRISPR could one day help cure many diseases, but there are ethical and safety concerns. Monsanto’s Driverless Car: Is CRISPR Gene Editing Driving Seed …Civil Eats BASF Licenses CRISPR-Cas9 Technology for Agriculture Use …Growing Produce Crispr Therapeutics AG’s (CRSP) Lock-Up Period Will End on April …Markets Daily |
Science Daily |
Time-lapse video reveals cells essential for ‘birth’ of blood stem cells
Science Daily “The research will likely open new avenues of investigation in stem cell biology and blood development and provide insight to aid efforts to make transplantable hematopoietic stem cells in the lab,” said corresponding author Wilson Clements, Ph.D., … |
Medical Xpress |
Personalized cell therapies show more promise in solid tumors
Medical Xpress Last year, O’Rourke and his colleagues reported that these CAR T cells successfully migrated to and infiltrated GBM tumors in nine patients, which has been an ongoing challenge in the treatment of many solid tumors with CAR because of an unfavorable … |